Skip to main content
  • 1357 Accesses

Abstract

Polycystic ovary syndrome (PCOS) is a complex syndrome affecting a considerable but variable proportion of women in reproductive age. Even if consensus statements underline that the reproductive outcomes in women with PCOS are worst only in the presence of oligo-anovulation, translational data on the reproductive compartments (i.e., ovary, oocyte, endometrium, etc.) demonstrate specificities in PCOS. Patients with PCOS have several comorbidities (i.e., obesity, insulin resistance, etc.) closely related to infertility and poor reproductive outcomes, and clinical data show a high rate of hospital admissions for infertility diagnosis and treatment in women with PCOS. Moreover, women with PCOS seem to have reproductive chances better than that expected. The heterogeneity of the phenotypes and the features of the syndrome certainly influence these findings. The current chapter will introduce in a provocative fashion the controversies on fertility and subfertility in women with PCOS discussed in the further chapters of the book.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens HR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377–84.

    Google Scholar 

  2. Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod. 2012;27:14–24.

    Article  Google Scholar 

  3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF, Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.

    Article  CAS  PubMed  Google Scholar 

  4. NIH Office of Disease Prevention. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome. Expert Panel Guidelines on PCOS. 2012, https://prevention.nih.gov/docs/programs/pcos/FinalReport.pdf.

  5. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36:487–525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Orio F, Palomba S. Reproductive endocrinology: new guidelines for the diagnosis and treatment of PCOS. Nat Rev Endocrinol. 2014;10:130–2.

    Article  PubMed  Google Scholar 

  8. Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10:624–36.

    Article  PubMed  Google Scholar 

  9. Yildiz BO, Azziz R, Androgen Excess and PCOS Society. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. Fertil Steril. 2010;94:690–3.

    Article  PubMed  Google Scholar 

  10. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO, ESE PCOS Special Interest Group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171:1–29.

    Article  Google Scholar 

  11. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89:505–22.

    Article  Google Scholar 

  12. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome—part 2. Endocr Pract. 2015;21:1415–26.

    Article  PubMed  Google Scholar 

  13. Palomba S, Falbo A, Zullo F. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance. Curr Opin Obstet Gynecol. 2009;21:465–73.

    Article  PubMed  Google Scholar 

  14. Palomba S, Falbo A, Di Cello A, Cappiello F, Tolino A, Zullo F. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. Fertil Steril. 2011;96:1128–33.

    Google Scholar 

  15. Dunaif A, Fauser BC. Renaming PCOS-a two-state solution. J Clin Endocrinol Metab. 2013;98:4325–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Palomba S, Daolio J, La Sala GB. Oocyte quality and competence in women with polycystic ovary syndrome. Trend Endocrinol Metab. 2017;28:186–98.

    Article  CAS  Google Scholar 

  17. Kuang H, Jin S, Hansen KR, Diamond MP, Coutifaris C, Casson P, Christman G, Alvero R, Huang H, Bates GW, Usadi R, Lucidi S, Baker V, Santoro N, Eisenberg E, Legro RS, Zhang H, Network RM. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome. Hum Reprod. 2015;30:2222–33.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007;356:551–66.

    Article  CAS  PubMed  Google Scholar 

  19. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H, NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371:119–29.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Lin TS. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod. 1999;14:167–71.

    Article  CAS  PubMed  Google Scholar 

  21. Sigala J, Sifer C, Dewailly D, Robin G, Bruyneel A, Ramdane N, Lefebvre-Khalil V, Mitchell V, Decanter C. Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study. Fertil Steril. 2015;103:112–8.

    Article  PubMed  Google Scholar 

  22. Holte J, Brodin T, Berglund L, Hadziosmanovic N, Olovsson M, Bergh T. Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries. Fertil Steril. 2011;96:594–9.

    Article  PubMed  Google Scholar 

  23. Wiser A, Shalom-Paz E, Hyman JH, Sokal-Arnon T, Bantan N, Holzer H, Tulandi T. Age-related normogram for antral follicle count in women with polycystic ovary syndrome. Reprod Biomed Online. 2013;27:414–8.

    Article  PubMed  Google Scholar 

  24. Kalra SK, Ratcliffe SJ, Dokras A. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate. Fertil Steril. 2013;100:208–13.

    Article  PubMed  Google Scholar 

  25. Ramezanali F, Ashrafi M, Hemat M, Arabipoor A, Jalali S, Moini A. Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotype: the predictive value of anti-Mullerian hormone. Reprod Biomed Online. 2016;32:503–12.

    Article  CAS  PubMed  Google Scholar 

  26. Garg D, Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod Biomed Online. 2016;33:15–28.

    Article  CAS  PubMed  Google Scholar 

  27. Christiansen SC, Eilertsen TB, Vanky E, Carlsen SM. Does AMH reflect follicle number similarly in women with and without PCOS? PLoS One. 2016;11:e0146739.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Dewailly D. Diagnostic criteria for PCOS: is there a need for a rethink? Best Pract Res Clin Obstet Gyneacol. 2016;37:5–11.

    Article  Google Scholar 

  29. Guzman L, Ortega-Hrepich C, Polyzos NP, Anckaert E, Verheyen G, Coucke W, Devroey P, Tournaye H, Smitz J, De Vos M. A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count. Hum Reprod. 2013;28:1261–6.

    Article  CAS  PubMed  Google Scholar 

  30. Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J Clin Endocrinol Metab. 2015;100:911–9.

    Article  CAS  PubMed  Google Scholar 

  31. Hudecova M, Holte J, Olovsson M, Sundström PI. Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod. 2009;24:1176–83.

    Article  CAS  PubMed  Google Scholar 

  32. Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12:13–21.

    Article  CAS  PubMed  Google Scholar 

  33. Barnhart KT. Live birth is the correct outcome for clinical trials evaluating therapy for the infertile couple. Fertil Steril. 2014;101:1205–8.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Legro RS, Wu X, Barnhart K, Niederberger C, Ng EH, Palomba S, Maria AS, Emilia R, Zhang H, Farquhar C, Rebar RW, Pellicer A, Reindollar R, Fauser BC, Tapanainen JS, Evers H, Shankaran S, Silver RM, Mol B, Norman RJ, Silver RM, Bhattacharya S, Vanderpoel S, Bhattacharya S, Evers JL, Ng EH, Niederberger C, Norman RJ, Palomba S, Pellicer A, Reindollar R, Rebar R, Shankaran S, Silver RM, Tapanainen JS, Vanderpool S, Zhang H. Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement. Hum Reprod. 2014;29:2075–82.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21:575–92.

    Article  PubMed  Google Scholar 

  36. Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril. 2010;94:1805–11.

    Article  PubMed  Google Scholar 

  37. Palomba S, Russo T, Falbo A, Di Cello A, Amendola G, Mazza R, Tolino A, Zullo F, Tucci L, La Sala GB. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. J Clin Endocrinol Metab. 2012;97:2441–9.

    Article  CAS  PubMed  Google Scholar 

  38. Palomba S, Russo T, Falbo A, Di Cello A, Tolino A, Tucci L, La Sala GB, Zullo F. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome. Hum Reprod. 2013;28:2838–47.

    Article  CAS  PubMed  Google Scholar 

  39. Palomba S, Falbo A, Chiossi G, Tolino A, Tucci L, La Sala GB, Zullo F. Early trophoblast invasion and placentation in women with different PCOS phenotypes. Reprod Biomed Online. 2014;29:370–81.

    Article  CAS  PubMed  Google Scholar 

  40. Sunkara SK, La Marca A, Seed PT, Khalaf Y. Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65868 singleton live birth outcomes. Hum Reprod. 2015;30:1473–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefano Palomba .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Palomba, S. (2018). Introduction. In: Palomba, S. (eds) Infertility in Women with Polycystic Ovary Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-45534-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-45534-1_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-45533-4

  • Online ISBN: 978-3-319-45534-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics